QIAGEN NV (QGE2.VI)
| Previous Close | 37.94 |
| Open | 38.19 |
| Bid | 38.80 x N/A |
| Ask | 38.88 x N/A |
| Day's Range | 38.02 - 38.85 |
| 52 Week Range | 36.63 - 41.36 |
| Volume | |
| Avg. Volume | 1,921 |
| Market Cap | 8.594B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.18 (2.83%) |
| Ex-Dividend Date | Jan 30, 2024 |
| 1y Target Est | N/A |
Insider Monkey7 Best Sites Like Ancestry.com to Research Your Family History
In this article, we take a look at 7 best sites like Ancestry.com to research your family history. If you would like to skip our detailed analysis of the genealogy industry, you can directly go to 3 Best Sites Like Ancestry.com to Research Your Family History. The Genealogy Industry Genealogy is the study of families, […]
GlobeNewswireQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control // Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB management and control amid globally rising incidence ratesVenlo, the Netherla
ZacksUnveiling Qiagen (QGEN) Q1 Outlook: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Qiagen (QGEN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
